Company profile: Rapport Therapeutics

1.1 - Company Overview

Rapport Therapeutics

Headquarter: United States

Founded: 20XX🔒

Employees: 100-500🔒

🌐 Website

Company description

Provider of precision medicines for neurological disorders, leveraging a RAP Technology Platform to discover and develop small-molecule therapies targeting specific neuronal receptor complexes. Programs include TARPγ8 AMPAR small molecules in clinical development for epilepsy with potential in pain and bipolar disorder, and discovery-stage nAChR modulators for chronic pain and hearing disorders.

Products and services

TARPγ8 AMPAR Programs: Clinical-stage small molecules selectively target TARPγ8 to modulate AMPAR activity, treating epilepsy with potential expansion to pain and bipolar disorder
RAP Technology Platform: Precision-engineered discovery system architects small-molecule therapeutics for CNS disorders by targeting specific neuronal receptor complexes
NAChR Programs: Discovery-stage modulators of nicotinic acetylcholine receptors aim to alleviate chronic pain and address hearing disorders through receptor-specific pharmacology

Key contacts

🔒

Financial details

🔒

1.2 - Competitors and similar companies to Rapport Therapeutics

Pharmaleads

HQ: France Website

Description: Provider of analgesic drug development focused on DENKIs, a new class of analgesics derived from highly potent and specific enkephalinase inhibitors, aiming to deliver improved pain relief for patients with severe chronic and acute pain without the side effects associated with other classes of analgesics.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Pharmaleads company profile →

Blockade Medical

HQ: United States Website

Description: Provider of catheter-based therapeutic devices for the treatment of cerebral aneurysms. Founded in 2011, Blockade Medical is a privately held company with a management team totaling 65+ years in the neurovascular field, committed to bringing products to market that are current standards of care.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Blockade Medical company profile →

Longeviti Neuro Solutions

HQ: United States Website

Description: Provider of implantable neurosurgical devices, developing and commercializing these products.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Longeviti Neuro Solutions company profile →

Adelia Therapeutics

HQ: United States Website

Description: Provider of a drug discovery platform developing proprietary tryptamine-based therapeutics to treat central nervous system (CNS) disorders.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Adelia Therapeutics company profile →

Link Medicine

HQ: United States Website

Description: Provider of research aimed at creating disease-modifying therapies for neurodegenerative diseases, including Alzheimer's and Parkinson's disease.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Link Medicine company profile →

🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒

🔒 View all strategic buyers with complete profiles

Start Free Trial →

2.2 - Strategic buyer groups for Rapport Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Products: ████████, ████████, ████████, ████████

🔒 View all companies in this group

Request Free Trial Now →

🔒

Buyer group 2: ████████ ████████

●● companies

Key Products: ████████, ████████, ████████, ████████

🔒 View all companies in this group

Request Free Trial Now →

🔒

Buyer group 3: ████████ ████████

●● companies

Key Products: ████████, ████████, ████████, ████████

🔒 View all companies in this group

Request Free Trial Now →

🔓 Unlock all detailed buyer group breakdowns with complete company profiles

Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Rapport Therapeutics

Buyout Funds
50+ funds

🔒

🔒

🔒

🔒

🔒 🇺🇸 Top US buyout funds investing in Rapport Therapeutics's sector and industry vertical
View Funds →
🔒 🇪🇺 Top Europe buyout funds in Rapport Therapeutics's sector and industry vertical
View Funds →

2.2 - Growth funds investing in similar companies to Rapport Therapeutics

Growth Equity Funds
40+ funds

🔒

🔒

🔒

🔒

🔒 🇺🇸 Top US growth equity funds investing in Rapport Therapeutics's sector and industry vertical
View Funds →
🔒 🇪🇺 Top Europe growth equity funds investing in Rapport Therapeutics's sector and industry vertical
View Funds →

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Rapport Therapeutics

4.2 - Public trading comparable groups for Rapport Therapeutics

🔒

Comparable group 1: ████████ ████████
●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Metrics: Avg EV/Revenue: ●.●x, Avg Growth: ●●%

Revenue growth

Median

15.7%

2025E

16.0%

2026E

EBITDA margin

Median

28.2%

2025E

28.6%

2026E

Cash EBITDA margin

Median

27.6%

2025E

28.0%

2026E

EV/Revenue

Median

8.4x

2025E

6.8x

2026E

EV/EBITDA

Median

28.9x

2025E

24.4x

2026E

EV/Cash EBITDA

Median

29.0x

2025E

25.5x

2026E

🔒 View all companies in this group
Request Free Trial Now →

🔒

Comparable group 2: ████████ ████████
●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Metrics: Avg EV/Revenue: ●.●x, Avg Growth: ●●%

Revenue growth

Median

15.7%

2025E

16.0%

2026E

EBITDA margin

Median

28.2%

2025E

28.6%

2026E

Cash EBITDA margin

Median

27.6%

2025E

28.0%

2026E

EV/Revenue

Median

8.4x

2025E

6.8x

2026E

EV/EBITDA

Median

28.9x

2025E

24.4x

2026E

EV/Cash EBITDA

Median

29.0x

2025E

25.5x

2026E

🔒 View all companies in this group
Request Free Trial Now →

🔒

Comparable group 3: ████████ ████████
●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Metrics: Avg EV/Revenue: ●.●x, Avg Growth: ●●%

Revenue growth

Median

15.7%

2025E

16.0%

2026E

EBITDA margin

Median

28.2%

2025E

28.6%

2026E

Cash EBITDA margin

Median

27.6%

2025E

28.0%

2026E

EV/Revenue

Median

8.4x

2025E

6.8x

2026E

EV/EBITDA

Median

28.9x

2025E

24.4x

2026E

EV/Cash EBITDA

Median

29.0x

2025E

25.5x

2026E

🔒 View all companies in this group
Request Free Trial Now →

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Rapport Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA

🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Rapport Therapeutics

What does Rapport Therapeutics do?

Rapport Therapeutics is a provider of precision medicines for neurological disorders, leveraging a RAP Technology Platform to discover and develop small-molecule therapies targeting specific neuronal receptor complexes. Programs include TARPγ8 AMPAR small molecules in clinical development for epilepsy with potential in pain and bipolar disorder, and discovery-stage nAChR modulators for chronic pain and hearing disorders.

Who are Rapport Therapeutics's competitors?

Rapport Therapeutics's competitors and similar companies include Pharmaleads, Blockade Medical, Longeviti Neuro Solutions, Adelia Therapeutics, and Link Medicine.

Where is Rapport Therapeutics headquartered?

Rapport Therapeutics is headquartered in United States.

How many employees does Rapport Therapeutics have?

Rapport Therapeutics has 1,000 employees 🔒.

When was Rapport Therapeutics founded?

Rapport Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Rapport Therapeutics in?

Rapport Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Rapport Therapeutics

Who are the top strategic acquirers in Rapport Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Rapport Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Rapport Therapeutics?

Top strategic M&A buyers groups and sectors for Rapport Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Rapport Therapeutics's sector and industry vertical

Which are the top PE firms investing in Rapport Therapeutics's sector and industry vertical?

Top PE firms investing in Rapport Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Rapport Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Rapport Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Rapport Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Rapport Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Rapport Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Rapport Therapeutics?

The key public trading comparables and valuation benchmarks for Rapport Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Rapport Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Rapport Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Rapport Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Rapport Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Rapport Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Rapport Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Rapport Therapeutics

Start Free Trial Book a Demo